Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
On July 2, 2025, the Food and Drug Administration (FDA) gave fast-track approval to sunvozertinib. This approval is for adults who have Non-Small-Cell Lung Cancer (NSCLC) (EGFR m), and whose cancer got worse after they had chemotherapy with platinum-based drugs. The mutation must be identified using a test approved by the FDA.
Source: AACR FDA Approval Alert 07/03/25
…